These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35433396)

  • 1. Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.
    Sannathimmappa MB; Nambiar V; Aravindakshan R
    Int J Crit Illn Inj Sci; 2022; 12(1):38-46. PubMed ID: 35433396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucormycosis.
    Reid G; Lynch JP; Fishbein MC; Clark NM
    Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019.
    Al-Ani RM
    World J Virol; 2022 Sep; 11(5):293-299. PubMed ID: 36188746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucor in a Viral Land: A Tale of Two Pathogens.
    Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
    Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
    Lynch JP; Fishbein MC; Abtin F; Zhanel GG
    Expert Rev Anti Infect Ther; 2023; 21(7):723-736. PubMed ID: 37262298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis: The Scathing Invader.
    Vasudevan B; Hazra N; Shijith KP; Neema S; Vendhan S
    Indian J Dermatol; 2021; 66(4):393-400. PubMed ID: 34759398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhino-orbital-cerebral mucormycosis.
    Gamaletsou MN; Sipsas NV; Roilides E; Walsh TJ
    Curr Infect Dis Rep; 2012 Aug; 14(4):423-34. PubMed ID: 22684277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.
    Naruka S; Rana N; Singh N; Kishore A; Nagpal K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):134S-144S. PubMed ID: 35176884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucormycosis: The hidden and forgotten disease.
    Darwish RM; AlMasri M; Al-Masri MM
    J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis.
    Steinbrink JM; Miceli MH
    Infect Dis Clin North Am; 2021 Jun; 35(2):435-452. PubMed ID: 34016285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
    Kamrul-Hasan AB; Selim S
    Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID19 associated mucormycosis: A review.
    Palanisamy PR; Elango D
    J Family Med Prim Care; 2022 Feb; 11(2):418-423. PubMed ID: 35360784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Cerebral Mucormycosis in the Post-COVID Period: A Detailed Analysis of Risk Factors, Clinical Progression, and Management of This Opportunistic Fungal Infection.
    Patel M; Panchal J; Desai C; Shah J; Prajapati B; Patel S
    Cureus; 2022 Nov; 14(11):e31220. PubMed ID: 36514560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.